Updated Jul 16, 2026
Mottola Frank is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $1.49M.
Frank Mottola is a corporate executive known for his roles at Supernus Pharmaceuticals, Inc., where he serves as Senior Vice President and Chief Technical Operations Officer. He has also held positions in Quality, GMP, Operations, and IT within the company.
| Role | SVP, Chief Tech. Ops. Officer |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-10 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale | 1.6K | $53.65 | $87K |
| 2026-03-10 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 1.8K | $54.73 | $98K |
| 2026-03-10 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | M — Option exercise | 3.8K | $0.00 | |
| 2026-02-26 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 977 | $50.69 | $50K |
| 2026-02-26 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | A — Grant or award | 1.9K | $0.00 | |
| 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 670 | $50.86 | $34K |
| 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | A — Grant or award | 1.2K | $0.00 | |
| 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 368 | $50.86 | $19K |
| 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | A — Grant or award | 750 | $0.00 | |
| 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 603 | $51.35 | $31K |
| 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | A — Grant or award | 1.1K | $0.00 | |
| 2025-09-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale | 5.0K | $45.87 | $229K |
| 2025-09-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | M — Option exercise | 5.0K | $39.40 | $197K |
| 2025-08-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale | 14.0K | $44.51 | $623K |
| 2025-08-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | M — Option exercise | 14.0K | $12.98 | $182K |
| 2024-11-08 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale | 15.0K | $36.98 | $555K |
| 2024-11-08 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | M — Option exercise | 15.0K | $9.13 | $137K |
Frank Mottola is a corporate executive known for his roles at Supernus Pharmaceuticals, Inc., where he serves as Senior Vice President and Chief Technical Operations Officer. He has also held positions in Quality, GMP, Operations, and IT within the company.…
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($1.49M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mottola Frank profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.